Clinical Trial Update: Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rituximab augmentation after R-CHOP induction chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Lymphoma, Large B-cell, Diffuse | Phase 2 | Status: UNKNOWN